The online version of this article (https://doi.org/10.1186/s12936-018-2182-z) contains supplementary material, which is available to authorized users.
Malaria has declined dramatically along the Thai–Myanmar border in recent years due to malaria control and elimination programmes. However, at the same time, artemisinin resistance has spread, raising concerns about the efficacy of parenteral artesunate for the treatment of severe malaria.
In November 2015 and April 2017, two patients were treated for severe malaria with parenteral artesunate. Quinine was added within 24 h due to an initial poor response to treatment. The first patient died within 24 h of starting treatment and the second did not clear his peripheral parasitaemia until 11 days later. Genotyping revealed artemisinin resistance Kelch-13 markers.
Reliable efficacy of artesunate for the treatment of severe malaria may no longer be assured in areas where artemisinin resistance has emerged. Empirical addition of parenteral quinine to artesunate for treatment is recommended as a precautionary measure.
World Health Organization. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015.
Phu NH, Day N, Diep PT, Ferguson DJP, White NJ. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg. 1995;89:200–4. CrossRef
Eder M, Farne H, Cargill T, Abbara A, Davidson RN. Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Pathog Glob Health. 2012;06:181–7. CrossRef
Kurth F, Develoux M, Mechain M, Clerinx J, Antinori S, Gjørup IE, et al. Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: the TropNet severe malaria study. Clin Infect Dis. 2015;61:1441–4. CrossRefPubMed
- Poor response to artesunate treatment in two patients with severe malaria on the Thai–Myanmar border
Aung Pyae Phyo
Kyaw Kyaw Win
Aung Myint Thu
Lei Lei Swe
Elizabeth A. Ashley
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II